Crossbow Therapeutics

Crossbow Therapeutics, Inc. is a biotechnology company dedicated to improving the lives of cancer patients by unlocking the therapeutic potential of T-cell receptor (TCR) mimic antibodies. The company's T-Bolt™ therapy is a next-generation, easy-to-assemble immunotherapy that enables high-precision targeting of previously unreachable cancer cell targets. Crossbow's efficient and selective approach aims to address the entire cancer proteome, significantly expanding the potential of antibody therapies to tackle various types of cancer.